Select Medical Holdings (FRA:S24) ROCE %: 8.94% (As of Mar. 2026)


FRA:S24 Select Medical Holdings Corp FRA:S24
77 GF Score
Price €14.40
GF Value €14.99
! 7 Warning Signs
View Full Analysis

What is Select Medical Holdings ROCE %?

Select Medical Holdings FRA:S24 +1.41% 77 ROCE % is 8.94% as of Mar. 2026. GuruFocus rates FRA:S24 with a GF Score™ of 77/100 and a GF Value™ of €14.99. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Select Medical Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.94%.


Select Medical Holdings  (FRA:S24) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Select Medical Holdings ROCE % Related Terms


Select Medical Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Select Medical Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Select Medical Holdings ROCE % Chart

Select Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.91 2.83 4.47 5.61 7.78

Select Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.51 8.12 7.14 6.61 8.94
FRA:S24
77GF Score
Select Medical Holdings Corp FRA:S24
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Select Medical Holdings ROCE % Calculation

Select Medical Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=333.65/( ( (5355.593 - 933.657) + (4997.257 - 840.758) )/ 2 )
=333.65/( (4421.936+4156.499)/ 2 )
=333.65/4289.2175
=7.78 %

Select Medical Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=382.084/( ( (4997.257 - 840.758) + (5226.402 - 839.366) )/ 2 )
=382.084/( ( 4156.499 + 4387.036 )/ 2 )
=382.084/4271.7675
=8.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.94% mean?
Select Medical Holdings (FRA:S24) has a ROCE % of 8.94% as of Mar. 2026.
Is Select Medical Holdings' ROCE % too high?
Select Medical Holdings' current ROCE % is 8.94%. The Healthcare Providers & Services industry median ROCE % is 6.42. Select Medical Holdings' value of 8.94% is 39.3% above this industry median. Overall, Select Medical Holdings has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Select Medical Holdings' ROCE % compare to SGRY and MD?
Select Medical Holdings' ROCE % of 8.94% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.42. Select Medical Holdings' value of 8.94% is 39.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.42, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Select Medical Holdings's current ROCE % of 8.94% is 39.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Select Medical Holdings's current ROCE % is 8.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Select Medical Holdings stock overvalued right now?
Select Medical Holdings (FRA:S24) has a current ROCE % of 8.94%. The stock's GF Value™ is €14.99, compared to a current price of €14.40 — trading 3.9% below its estimated fair value. The current ROCE % is 8.94% and 39.3% above the Healthcare Providers & Services industry median of 6.42. Select Medical Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Select Medical Holdings (FRA:S24), the current ROCE % is 8.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Select Medical Holdings (FRA:S24) Overvalued in 2026?

Based on GuruFocus' analysis, Select Medical Holdings stock appears to be undervalued. The current stock price of €14.40 is trading 3.9% below its estimated GF Value™ of €14.99.

Key valuation signals for FRA:S24:

  • ROCE %: 8.94%
  • GF Value™: €14.99 vs. price of €14.40 (3.9% below fair value)
  • GF Score™: 77/100 with 7 warning signs
  • Industry Position: 39.3% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:S24 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Select Medical Holdings Business Description

Other Exchanges SEM:USA
Address 4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA, USA, 17055
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
77GF Score

Get the complete analysis for FRA:S24

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.40
Price
€14.99
GF Value